Uncovering GLP-1s | E03: The Truth About Obesity In India: Uncensored | Earlyfit | Novo Nordisk скачать в хорошем качестве

Uncovering GLP-1s | E03: The Truth About Obesity In India: Uncensored | Earlyfit | Novo Nordisk

Uncover the truth about obesity with two of India's leading endocrinologists, Dr. Saptarshi Bhattacharya and Dr. Simran Thakkar, hosted by Saloni Paliwal, co-founder at Earlyfit, in a special World Obesity Day collaboration with Novo Nordisk. Obesity is not a lack of willpower, it is a chronic, relapsing metabolic disease. And for Indians, the risks run deeper than most realise. In this episode, we unpack why "eat less, move more" isn't enough, what's really driving India's obesity epidemic, and why 250 million Indians are at risk right now. We will cover: ▪️ Why obesity is a disease, not a lifestyle failure ▪️ The "Thin Fat Phenotype": Why Indians carry dangerous visceral fat even when they look slim ▪️ The role of GLP-1 & GIP hormones in appetite, insulin resistance & weight loss ▪️ Why muscle & protein are non-negotiable for metabolic health ▪️ The real cost: Treating obesity vs. paying for its complications Inspired? 🔗 Visit: https://www.novocare.in/ https://early.fit/ Follow us on Instagram: @novonordisk @joinearly.fit ⏱️ Timestamps: 00:00 Intro 02:00 Fat or Obese? There's a Difference & It Matters 04:19 The Thin Fat Phenotype: Why Indians Are at Higher Risk 05:35 Silent Disease: Feeling Fine But Still at Risk 07:55 The #1 Lifestyle Change for Weight Loss 09:00 Why Protein & Strength Training Matter More Than You Think 10:22 GLP-1 & GIP Hormones Explained 16:20 Are medical interventions a shortcut? 17:00 Risks vs. Benefits: How Doctors Evaluate Treatment 18:45 Common Myths: "I'll Lose My Glow" & Other Misconceptions 19:32 250 million Indians are obese. Why? 21:14 The Cost of NOT Treating Obesity 22:33 Closing Advice: How to Start Your Weight Loss Journey Safely #weightloss #glp1 #obesity #metabolichealth #insulinresistance #EarlyFit #NovoNordisk #WorldObesityDay #semaglutide #tirzepatide #bariatrichealth #longevity #healthpodcast #endocrinology #thinfatphenotype #obesityinIndia ⚠️ Disclaimer: For people living with over weight and obesity weight management outcomes may vary depending on their treatment journeys, which should be pursued under the guidance of a registered healthcare professional. Ref: Dent Ret al. Metabolism. 2020 Dec 1;113:154388 This information is for educational purposes only and is not meant to replace medical advice. Always reach out to your registered healthcare professional for more information. Apis Bull logo is a registered trademark of Novo Nordisk A/S. Medical references: Horn et al. Postgrad Med 2022; 134:359-75. Wharton Set al. CMAJ. 2020 Aug 4;192(31):E875-E891.